Home / Resource Library / ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profilingICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling Study discusses a risk model for ICANS in CAR-T therapy.